Environmental enteric dysfunction: A review of potential mechanisms, consequences and management strategies

BMC Medicine

Volumn 17, Issue 1, 2019, Pages

  Tickell, Kirkby D ^a,b   Atlas, Hannah E ^a   Walson, Judd L ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b The Childhood Acute Illness and Nutrition Network (CHAIN)   (Kenya)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute malnutrition; Childhood malnutrition; Enteric dysfunction; Environmental enteric dysfunction; Stunting

Indexed keywords

ADVERSE OUTCOME; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; ENVIRONMENTAL ENTERIC DYSFUNCTION; ENVIRONMENTAL EXPOSURE; HORMONE RESISTANCE; HUMAN; INTESTINE FUNCTION DISORDER; MALABSORPTION; MALNUTRITION; MIDDLE INCOME COUNTRY; NONHUMAN; PREVENTION STUDY; REVIEW; STRATEGIC PLANNING; STUNTING; SYSTEMIC DISEASE; ADVERSE EVENT; ANIMAL; CLINICAL TRIAL (TOPIC); COMPLICATION; ENTERITIS; PATHOPHYSIOLOGY; POLLUTION; SMALL INTESTINE;

ANIMALS; CLINICAL TRIALS AS TOPIC; ENTERITIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTION; HUMANS; INTESTINE, SMALL;

EID: 85075498246     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-019-1417-3     Document Type: Review

References (65)

1. Keusch GTPA, Troncale FJ. Subclinical malabsorption in Thailand. II. Intestinal absorption in American military and peace corps personnel. Am J Clin Nutr. 1972;25(10):1067-79.
2. Lindenbaum JKT, Sprinz H. Malabsorption and jejunitis in American peace corps volunteers in Pakistan. Ann Intern Med. 1966;65(6):1201-9.
3. Lindenbaum JGC, Kent TH. Recovery of small-intestinal structure and function after residence in the tropics. I. Studies in peace corps volunteers. Ann Intern Med. 1971;74(2):218-22.
4. Korpe PS, Petri WA. Jr.Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med. 2012;18(6):328-36.
5. Louis-Auguste J, Kelly P. Tropical enteropathies. Curr Gastroenterol Rep. 2017;19(7):29.
6. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, Lavery JV, et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr Bull. 2013;34(4):357-64.
7. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis. 2014;59(Suppl 4):S207-12.
8. Campbell RK, Schulze KJ, Shaikh S, Mehra S, Ali H, Wu L, et al. Biomarkers of environmental enteric dysfunction among children in rural Bangladesh. J Pediatr Gastroenterol Nutr. 2017;65(1):40-6.
9. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg. 2013;88(2):390-6.
10. Guerrant RL, Leite AM, Pinkerton R, Medeiros PH, Cavalcante PA, DeBoer M, et al. Biomarkers of environmental enteropathy, inflammation, stunting, and impaired growth in children in Northeast Brazil. PLoS One. 2016;11(9):e0158772.
11. McCormick BJJ, Lee GO, Seidman JC, Haque R, Mondal D, Quetz J, et al. Dynamics and trends in fecal biomarkers of gut function in children from 1-24 months in the MAL-ED study. Am J Trop Med Hyg. 2017;96(2):465-72.
12. Owino V, Ahmed T, Freemark M, Kelly P, Loy A, Manary M, et al. Environmental enteric dysfunction and growth failure/stunting in global child health. Pediatrics. 2016;138(6):e20160641.
13. Denno DM, Tarr PI, Nataro JP. Environmental enteric dysfunction: a case definition for intervention trials. Am J Trop Med Hyg. 2017;97(6):1643-6.
14. Exum NG, Lee GO, Olortegui MP, Yori PP, Salas MS, Trigoso DR, et al. A longitudinal study of household water, sanitation, and hygiene characteristics and environmental enteropathy markers in children less than 24 months in Iquitos, Peru. Am J Trop Med Hyg. 2018;98(4):995-1004.
15. Liu J, Gratz J, Amour C, Nshama R, Walongo T, Maro A, et al. Optimization of quantitative PCR methods for enteropathogen detection. PLoS One. 2016;11(6):e0158199.
16. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291-301.
17. Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1309-18.
18. Kosek MN, Network Investigators MAL-ED. Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study. EBioMedicine. 2017;18:109-17.
19. Rogawski ET, Liu J, Platts-Mills JA, Kabir F, Lertsethtakarn P, Siguas M, et al. Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1319-28.
20. MAL-ED Network Investigators. Childhood stunting in relation to the pre- and postnatal environment during the first 2 years of life: the MAL-ED longitudinal birth cohort study. PLoS Med. 2017;14(10):e1002408.
21. McGrath CJ, Arndt MB, Walson JL. Biomarkers to stratify risk groups among children with malnutrition in resource-limited settings and to monitor response to intervention. Horm Res Paediatr. 2017;88(1):111-7.
22. Prendergast AJ, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One. 2014;9(2):e86928.
23. Rytter MJ, Kolte L, Briend A, Friis H, Christensen VB. The immune system in children with malnutrition - a systematic review. PLoS One. 2014;9(8):e105017.
24. Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR. Environmental enteric dysfunction pathways and child stunting: a systematic review. PLoS Negl Trop Dis. 2018;12(1):e0006205.
25. Kosek MN, Mduma E, Kosek PS, Lee GO, Svensen E, Pan WKY, et al. Plasma tryptophan and the kynurenine-tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy. Am J Trop Med Hyg. 2016;95(4):928-37.
26. Syed S, Ali A, Duggan C. Environmental enteric dysfunction in children. J Pediatr Gastroenterol Nutr. 2016;63(1):6-14.
27. Guillen B, Atherton NS. Short bowel syndrome. In: StatPearls. Treasure Island, FL: StatPearls; 2019. https://www.ncbi.nlm.nih.gov/books/NBK536935/. Accessed 04 Feb 2019.
28. Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science. 2016;351(6275):aad3311.
29. Nataro JP, Guerrant RL. Chronic consequences on human health induced by microbial pathogens: growth faltering among children in developing countries. Vaccine. 2017;3549 Pt A:6807-12.
30. Arndt MB, Richardson BA, Mahfuz M, Ahmed T, Haque R, Gazi MA, et al. Plasma fibroblast growth factor 21 is associated with subsequent growth in a cohort of underweight children in Bangladesh. Curr Dev Nutr. 2019;3(5):nzz024.
31. Gora MJ, Sauk JS, Carruth RW, Gallagher KA, Suter MJ, Nishioka NS, et al. Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure. Nat Med. 2013;19(2):238-40.
32. Thompson AJ, Hughes M, Anastasova S, Conklin LS, Thomas T, Leggett C, et al. Position paper: the potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction. Nat Rev Gastroenterol Hepatol. 2017;14(12):727-38.
33. Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis. 2014;59(Suppl 4):S213-9.
34. Faubion WA, Camilleri M, Murray JA, Kelly P, Amadi B, Kosek MN, et al. Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene. BMJ Glob Health. 2016;1(1):e000066.
35. Arndt MB, Richardson BA, Ahmed T, Mahfuz M, Haque R, John-Stewart GC, et al. Fecal markers of environmental enteropathy and subsequent growth in Bangladeshi children. Am J Trop Med Hyg. 2016;95(3):694-701.
36. Iqbal NT, Sadiq K, Syed S, Akhund T, Umrani F, Ahmed S, et al. Promising biomarkers of environmental enteric dysfunction: a prospective cohort study in Pakistani children. Sci Rep. 2018;8(1):2966.
37. Denno DM, VanBuskirk KM, Nelson ZC, Musser CA, Tarr PI. Environmental enteric dysfunction: advancing current knowledge. St Louis: Washington University Libraries; 2016.
38. Mahfuz M, Das S, Mazumder RN, Masudur Rahman M, Haque R, Bhuiyan MMR, et al. Bangladesh environmental enteric dysfunction (BEED) study: protocol for a community-based intervention study to validate non-invasive biomarkers of environmental enteric dysfunction. BMJ Open. 2017;7(8):e017768.
39. ClinicalTrials.gov. Identifier NCT03588013, Study of Environmental Enteropathy and Malnutrition in Pakistan (SEEM); 2018. https://clinicaltrials.gov/ct2/show/NCT03588013?term=NCT03588013&rank=1. Accessed 04 Feb 2019.
40. Luby SP, Rahman M, Arnold BF, Unicomb L, Ashraf S, Winch PJ, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial. Lancet Glob Health. 2018;6(3):e302-15.
41. Null C, Stewart CP, Pickering AJ, Dentz HN, Arnold BF, Arnold CD, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2018;6(3):e316-29.
42. Humphrey JH, Mbuya MNN, Ntozini R, Moulton LH, Stoltzfus RJ, Tavengwa NV, et al. Independent and combined effects of improved water, sanitation, and hygiene, and improved complementary feeding, on child stunting and anaemia in rural Zimbabwe: a cluster-randomised trial. Lancet Glob Health. 2019;7(1):e132-47.
43. Jones KD, Hünten-Kirsch B, Laving AM, Munyi CW, Ngari M, Mikusa J, et al. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med. 2014;12:133.
44. Pavlinac PB, Singa BO, John-Stewart GC, Richardson BA, Brander RL, McGrath CJ, et al. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto bora trial). BMJ Open. 2017;7(12):e019170.
45. DeBoer MD, Platts-Mills JA, Scharf RJ, McDermid JM, Wanjuhi AW, Gratz J, et al. Early life interventions for childhood growth and development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide. BMJ Open. 2018;8(7):e021817.
46. Gough EK, Moodie EE, Prendergast AJ, Johnson SM, Humphrey JH, Stoltzfus RJ, et al. The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:2267.
47. Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, et al. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N Engl J Med. 2018;378(17):1583-92.
48. Rogawski ET, Platts-Mills JA, Seidman JC, John S, Mahfuz M, Ulak M, et al. Use of antibiotics in children younger than two years in eight countries: a prospective cohort study. Bull World Health Organ. 2017;95(1):49-61.
49. Qazi SA, Rehman GN, Khan MA. Standard management of acute respiratory infections in a children's hospital in Pakistan: impact on antibiotic use and case fatality. Bull World Health Organ. 1996;75(4):501-7.
50. Galpin L, Manary MJ, Fleming K, Ou CN, Ashorn P, Shulman RJ. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. Am J Clin Nutr. 2005;82(5):1040-5.
51. Stephenson KB, Agapova SE, Divala O, Kaimila Y, Maleta KM, Thakwalakwa C, et al. Complementary feeding with cowpea reduces growth faltering in rural Malawian infants: a blind, randomized controlled clinical trial. Am J Clin Nutr. 2017;106(6):1500-7.
52. Agapova SE, Stephenson KB, Divala O, Kaimila Y, Maleta KM, Thakwalakwa C, et al. Additional common bean in the diet of Malawian children does not affect linear growth, but reduces intestinal permeability. J Nutr. 2018;148(2):267-74.
53. Cheng WD, Wold KJ, Bollinger LB, Ordiz MI, Shulman RJ, Maleta KM, et al. Supplementation with lactoferrin and lysozyme ameliorates environmental enteric dysfunction: a double-blind, randomized, placebo-controlled trial. Am J Gastroenterol. 2019;114(4):671-8.
54. Desai A, Smith LE, Mbuya MN, Chigumira A, Fundira D, Tavengwa NV, et al. The SHINE trial infant feeding intervention: pilot study of effects on maternal learning and infant diet quality in rural Zimbabwe. Clin Infect Dis. 2015;61(Suppl 7):S710-5.
55. De-Regil LM, Suchdev PS, Vist GE, Walleser S, Peña-Rosas JP. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database Syst Rev. 2011;(9):CD008959.
56. Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XHS, Chan ES, et al. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev. 2014;(5):CD009384.
57. ClinicalTrials.gov. Identifier NCT03716115, Therapeutic Approaches to Malnutrition Enteropathy (TAME); 2018. https://clinicaltrials.gov/ct2/show/NCT03716115?term=Therapeutic+Approaches+to+Malnutrition+Enteropathy+%28TAME%29&rank=1. Accessed 04 May 2019.
58. ClinicalTrials.gov. Identifier NCT03263871, pilot study of PTM202 for the treatment of environmental enteric dysfunction (EED). https://clinicaltrials.gov/ct2/show/NCT03263871?term=Pilot+Study+of+PTM202+for+the+Treatment+of+Environmental+Enteric+Dysfunction+%28EED%29&rank=1. Accessed 04 May 2019.
59. Salvatore S, Heuschkel R, Tomlin S, Davies SE, Edwards S, Walker-Smith JA, et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14(12):1567-79.
60. Cohn DA, Kelly MP, Bhandari K, Zoerhoff KL, Batcho WE, Drabo F, et al. Gender equity in mass drug administration for neglected tropical diseases: data from 16 countries. Int Health. 2019;ihz012. https://doi.org/10.1093/inthealth/ihz012.
61. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382(9890):452-77.
62. Puett C, Sadler K, Alderman H, Coates J, Fiedler JL, Myatt M. Cost-effectiveness of the community-based management of severe acute malnutrition by community health workers in southern Bangladesh. Health Policy Plan. 2013;28(4):386-99.
63. Horton S, Shekar M, McDonald D, Mahal A, Brooks JK. Scaling up nutrition - what will it cost? Washington, DC: World Bank; 2010.
64. United Nations Children's Fund (UNICEF). Management of severe acute malnutrition in children: working towards results at scale. New York: UNICEF; 2015.
65. United Nations Children's fund (UNICEF). Diarrhoeal disease. 2018. https://data.unicef.org/topic/child-health/diarrhoeal-disease/. Accessed 04 May 2019.